Sagespring Wealth Partners’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$277K Sell
3,856
-3,123
-45% -$294K ﹤0.01% 721
2026
Q1
$825K Buy
6,979
+3,939
+130% +$487K 0.02% 372
2025
Q4
$382K Buy
3,040
+586
+24% +$76.4K 0.01% 549
2025
Q3
$359K Sell
2,454
-1,418
-37% -$214K 0.01% 549
2025
Q2
$604K Buy
3,872
+402
+12% +$63.7K 0.01% 385
2025
Q1
$571K Buy
3,470
+984
+40% +$164K 0.01% 358
2024
Q4
$405K Buy
+2,486
New +$445K 0.01% 394

Other funds holding ZTS

Sagespring Wealth Partners's ZTS Position: Q2 2026 in Review

Sagespring Wealth Partners reduced its Zoetis (ZTS) stake by 45% in Q2 2026, selling an estimated $294K and leaving 3,856 shares worth $277K. The position accounts for ﹤0.01% of the portfolio, ranked #721.

Sagespring Wealth Partners first reported a position in ZTS in Q4 2024 and has held it in 7 quarters since. The position peaked at $825K in Q1 2026. 880 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Sagespring Wealth Partners held 3,856 shares of Zoetis worth $277K as of Q2 2026.
  • Sagespring Wealth Partners sold 3,123 Zoetis shares in Q2 2026, an estimated $294K.
  • Zoetis made up ﹤0.01% of Sagespring Wealth Partners's portfolio in Q2 2026, its #721 holding.
  • Sagespring Wealth Partners first reported a position in Zoetis in Q4 2024 and has held it in 7 quarters since.
  • Sagespring Wealth Partners's Zoetis position peaked at $825K in Q1 2026.
  • 880 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Sagespring Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.